Currently out of the existing stock ratings of Amit Hazan, 59 are a HOLD (36.2%), 87 are a BUY (53.37%), 17 are a SELL (10.43%).

Amit Hazan

Work Performance Price Targets & Ratings Chart

Analyst Amit Hazan, carries an average stock price target met ratio of 73.11% that have a potential upside of 20.03% achieved within 239 days. Previously, Amit Hazan worked at GOLDMAN SACHS.

Amit Hazan’s has documented 286 price targets and ratings displayed on 25 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on INSP, Inspire Medical Systems at 13-Dec-2022.

Wall Street Analyst Amit Hazan

Analyst best performing recommendations are on ATEC (ALPHATEC HOLDINGS).
The best stock recommendation documented was for ATEC (ALPHATEC HOLDINGS) at 8/8/2022. The price target of $9.5 was fulfilled within 4 days with a profit of $1.51 (18.9%) receiving and performance score of 47.25.

Average potential price target upside

of $182.03 (58.92%) on OM (OUTSET MEDICAL ).
of $50.17 (34.51%) on INSP (INSPIRE MEDICAL SYSTEMS).
of $41.76 (21.4%) on BDX (BECTON DICKINSON AND COMPANY).

ABT Abbott Laboratories BAX Baxter International BDX Becton Dickinson and Company BSX Boston Scientific Corp BVS Bioventus EW Edwards Lifesciences Corp INSP Inspire Medical Systems ISRG Intuitive Surgical JNJ Johnson & Johnson MDT Medtronic PLC SYK Stryker VAR Varian Medical Systems ZBH Zimmer Biomet Holdings ESTA Establishment Labs Holdings AFIB Acutus Medical ATEC Alphatec Holdings LIVN LivaNova PLC SHC Sotera Health Co BLCO Bausch + Lomb Corp OM Outset Medical SKIN Beauty Health Co AGTI Agiliti PRCT Procept Biorobotics Corp ARAY Accuray IART Integra LifeSciences Holdings

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Matt Miksic (BARCLAYS)